Market Place
Sourcing Support
TerSera® Presents Patient-Reported Clinical and Productivity Outcomes
09 Nov 2021 //
PRNEWSWIRE
TerSera® Announces Publication Of Real-World Study On Xermelo®
27 Oct 2021 //
PRNEWSWIRE
Lexicon bids farewell to top seller Xermelo in reorganization toward R&D
30 Jul 2020 //
ENDPTS
Lexicon Announces Preclinical Efficacy Data on Telotristat Ethyl’s
13 May 2020 //
GLOBENEWSWIRE
Lexicon Reports Second Q 2018 Financial Results & Provides a Business Update
30 Jul 2018 //
GLOBENEWSWIRE
Lexicon to Highlight Pipeline Progress at R&d Day on April 10, 2018
24 May 2018 //
PRESS RELEASE
FDA to review Zynquista™ (sotagliflozin) as potential treatment for ty1 diabetes
22 May 2018 //
PRESS RELEASE
Lexicon Announces Publication of New XERMELO®Data in Clinical Therapeutics
04 May 2018 //
PRESS RELEASE
European Commission Approves XERMELO®For The Treatment Of Carcinoid Syndrome
06 Sep 2017 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.